Phreesia, Inc. (NYSE:PHR) shares saw unusually-high trading volume on Thursday . Approximately 31,900 shares changed hands during trading, a decline of 93% from the previous session’s volume of 466,407 shares.The stock last traded at $55.91 and had previously closed at $52.54.
PHR has been the topic of several recent research reports. Smith Barney Citigroup lifted their target price on shares of Phreesia from $33.00 to $59.00 in a research note on Monday, December 14th. Robert W. Baird initiated coverage on shares of Phreesia in a research note on Thursday, April 1st. They set an “outperform” rating and a $60.00 target price on the stock. Piper Sandler reaffirmed an “overweight” rating and set a $58.00 target price (up previously from $56.00) on shares of Phreesia in a research note on Wednesday, March 31st. DA Davidson lifted their target price on shares of Phreesia from $35.00 to $70.00 and gave the stock a “buy” rating in a research note on Thursday, December 10th. Finally, SVB Leerink lowered their target price on shares of Phreesia from $85.00 to $75.00 and set an “outperform” rating on the stock in a research note on Thursday, April 1st. Three equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Phreesia has an average rating of “Buy” and an average price target of $52.07.
The firm has a market cap of $2.39 billion, a PE ratio of -87.57 and a beta of 1.42. The firm has a fifty day moving average price of $59.33 and a 200 day moving average price of $51.77. The company has a current ratio of 7.24, a quick ratio of 7.24 and a debt-to-equity ratio of 0.09.
In related news, Director Edward L. Cahill sold 15,000 shares of the company’s stock in a transaction that occurred on Thursday, April 1st. The stock was sold at an average price of $54.94, for a total value of $824,100.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Amy Beth Vanduyn sold 21,829 shares of the company’s stock in a transaction that occurred on Friday, January 29th. The shares were sold at an average price of $65.91, for a total value of $1,438,749.39. The disclosure for this sale can be found here. Insiders have sold 358,526 shares of company stock worth $23,312,344 over the last quarter. Insiders own 28.20% of the company’s stock.
Hedge funds and other institutional investors have recently modified their holdings of the business. California Public Employees Retirement System raised its stake in shares of Phreesia by 12.1% during the fourth quarter. California Public Employees Retirement System now owns 66,919 shares of the company’s stock worth $3,631,000 after purchasing an additional 7,219 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of Phreesia by 17.5% during the third quarter. Charles Schwab Investment Management Inc. now owns 200,130 shares of the company’s stock worth $6,431,000 after purchasing an additional 29,771 shares during the last quarter. American International Group Inc. raised its position in Phreesia by 13.1% in the fourth quarter. American International Group Inc. now owns 19,323 shares of the company’s stock worth $1,048,000 after acquiring an additional 2,231 shares in the last quarter. Paloma Partners Management Co acquired a new stake in Phreesia in the fourth quarter valued at $231,000. Finally, Nichols & Pratt Advisers LLP MA acquired a new stake in Phreesia in the fourth quarter valued at $960,000. Institutional investors own 75.38% of the company’s stock.
About Phreesia (NYSE:PHR)
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company's Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments.
Recommended Story: Consumer Price Index (CPI)
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.